Table 2.
Characteristics of Participants Included in Individual Studies
| Study | Mean (SD) age of participants, y |
Mean (SD) no. of comorbidities; duration of dialysis, mean (SD/range) |
Inclusion criteria |
|---|---|---|---|
| Cheema 20077 | Exp: 60.0 (14.2) Con: 65.0 (15.3) |
Exp: 4.9 (1.6); 3.3 (0.3–16.7) y Con: 5.2 (2.0); 1.6 (0.6–10.3) y |
Age >18 y; >3 mo on HD; without acute or chronic medical condition that could preclude PRT of data collection; able to ambulate without assistive devices >50m; Kt/V ≥1.2; stable during dialysis. |
| Chen 201026 | Exp: 71.1 (12.6) Con: 66.9 (13.4) |
Exp: 7.3 (2.9); 1.54 (0.14) Con: 6.3 (2.4); 1.65 (0.38) |
Age >30 y; serum albumin <4.2 g/dl; on HD 3×/week and 80% compliance. |
| Dong 201121 | Exp: 46.5 (12.1) Con: 40.2 (13.5) |
Co-morbidities and duration of dialysis not indicated | Age >18 y; >3 mo on HD; Kt/V ≥1.2; on HD 3×/week using bio-compatible HD membrane. |
| Johansen 200625 | Exp: 54.4 (13.6) Con: 56.8 (13.8) |
% of participants with DM, CAD, HTN, PAD and CVA in both groups has been reported. Total number of comorbidities not reported. Exp: 33.0 (3.5–108) mo Con: 25.5 (3–156) mo |
Kt/V ≥1.2; on HD 3×/week; free of HIV and malignancy; did not have infection in the past 3 mo. |
| Kopple 200627 | Exp: (a) ET 45.9 (4.1) (b) ST46.0 (2.7) (c) EST 42.7 (3.8) |
No. of comorbidities not indicated; Exp: 45.9(4.1) mo Con: 51.4(21.0) mo Exp: 46.0(2.7) mo Con: 51.4(21.0) mo Exp: 42.7(3.8) mo Con: 51.4(21.0) mo |
Age 25–65 y; Clinically stable HD; on HD 3×/week. |
Exp=experimental; Con=control; HD=haemodialysis; PRT=progressive resistance training; DM=diabetes mellitus; CAD=coronary artery disease; HTN=hypertension; PAD=peripheral arterial disease; CVA=cerebro-vascular accident; ET=endurance training; ST=strength training; EST=endurance and strength training.